EIDX News and Press, Eidos Therapeutics Inc. From 01/04/21

Merger activity decreased last week with one new deal announced. The acquisition of Red Lion Hotels (RLH) by Sonesta International Hotels. Perella Weinberg Partners and FinTech Acquisition Corp. IV enter into a definitive business combination agreement. For further details s...

PALO ALTO, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) today announced that leading proxy advisory firm Institutional Shareholder Services (“ISS”) recommends that BridgeBio stockholders and Eidos Therapeutics, Inc. (Nasdaq: EIDX) stockholder...

WeissLaw LLP Reminds MTSC, EIDX, IPHI, and ALXN Shareholders About Its Ongoing Investigations PR Newswire NEW YORK , Dec. 30, 2020 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our inves...

NEW YORK, NY / ACCESSWIRE / December 29, 2020 / Labaton Sucharow, a nationally ranked shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims against clinical-stage biotech company Eidos Therapeutics. (NASDAQ:EIDX). If you currently ow...

Merger activity remained steady last week with seven new deals announced. The acquisition of RealPage by Thoma Bravo. The acquisition of QEP Resources by Diamondback Energy. For further details see: Merger Arbitrage Mondays: Deal-Making In 2020 Ends With A Bang

NEW YORK, NY / ACCESSWIRE / December 26, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Cellular Biomedicine Group, Inc. (NASDAQ: CBMG...

M&A momentum continued to build with seven new deals announced. Lockheed Martin Corporation (LMT) announced that it is acquiring Aerojet Rocketdyne Holdings (AJRD). The acquisition of TC PipeLines (TCP) by TC Energy Corporation (TRP). For further details see: Merger ...

NEW YORK, NY / ACCESSWIRE / December 16, 2020 / Labaton Sucharow, a nationally ranked shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims against clinical-stage biotech company Eidos Therapeutics. (NASDAQ:EIDX). If you currently ow...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Vaccine rolloutLess than two days after the FDA granted emergency authorization for Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) COVID-19 vaccine, nearly...

A bout of dealmaking began over the weekend as AstraZeneca bulked up its rare disease portfolio with the $39B purchase of Alexion Pharmaceuticals (its biggest acquisition on record).Elsewhere in the pharma sector, GlaxoSmithKline (GSK) was reported to be in the race to buy Eidos Therapeutics ...